Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
TPST
Stock Latest News
Company Announcements
Tempest Therapeutics’ Promising Advances in Liver Cancer Treatment
23d ago
TPST
Premium
The Fly
Tempest Therapeutics receives NMPA clearance to proceed with amezalpat trial
26d ago
TPST
Premium
Company Announcements
Tempest Therapeutics Secures $4.1M in Direct Offering
1M ago
8K
TPST
Premium
The Fly
Tempest prices 739,000 shares at $6.25 in registered direct offering
2M ago
TPST
Premium
Company Announcements
Tempest Therapeutics Shifts Executives to Consulting Roles
2M ago
8K
TPST
Premium
The Fly
Tempest Therapeutics receives ODD from EMA for amezalpat
2M ago
TPST
Premium
Company Announcements
Tempest Therapeutics Reports Q1 2025 Financial Results
2M ago
TPST
Premium
Ratings
Tempest Therapeutics: Navigating Financial Challenges with Promising Clinical Data and Strategic Partnerships
2M ago
TPST
Premium
The Fly
Tempest Therapeutics reports Q1 EPS ($3.16), consensus ($3.29)
2M ago
TPST
Premium
Ratings
Cautious Optimism for Tempest Therapeutics Amid Strategic Reorganization and Promising Amezalpat Data
3M ago
TPST
Premium
The Fly
Tempest Therapeutics announces FDA granted ODD to TPST-1495
3M ago
TPST
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
ADTX
CRMD
Premium
The Fly
Tempest Therapeutics downgraded at Scotiabank as amezalpat finds no suitors
4M ago
CHRO
TPST
Premium
The Fly
Tempest Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
4M ago
TPST
Premium
The Fly
Tempest Therapeutics downgraded to Sector Perform from Outperform at Scotiabank
4M ago
TPST
Premium
Company Announcements
Tempest Therapeutics Terminates Loan Agreement with Oxford
4M ago
8K
TPST
Premium
The Fly
Tempest Therapeutics to explore strategic alternatives
4M ago
TPST
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
BMY
ARTV
Premium
The Fly
Tempest Therpeutics trading halted, news pending
4M ago
TPST
Premium
The Fly
Tempest Therapeutics treatment of FAP granted FDA orphan designation
4M ago
TPST
Premium
Company Announcements
Tempest Therapeutics Advances Cancer Therapies Amid Financial Challenges
4M ago
TPST
Premium
The Fly
Tempest Therapeutics price target lowered to $7 from $13 at Scotiabank
4M ago
TPST
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
